Prokidney PROK
NASDAQ PROK
$1.71 +0.05 (+3.01%)
At close: Oct 1, 2026 · 4:00 PM EDT

Prokidney (PROK) Non-Current Deffered Revenue (2021 - 2022)

Updated

Prokidney's Non-Current Deffered Revenue was $7.7 million in Q2 2022, unchanged from the prior quarter.

Analysis

Prokidney (PROK) Non-Current Deffered Revenue (2021 - 2022) Analysis & Trends

From Q3 2021 onward, Prokidney has reported Non-Current Deffered Revenue for 4 quarters.

  • Per Business Quant data, PROK's Non-Current Deffered Revenue in the three quarters before Q2 2022 was $7.7 million (Q1 2022), $7.7 million (Q4 2021) and $7.7 million (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Prokidney 848.66 Mn 1.96 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 7.70 Mn
Mar 31, 2022 7.70 Mn
Dec 31, 2021 7.70 Mn
Sep 30, 2021 7.70 Mn
API Access

Prokidney Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=PROK&period=max&api_key=YOUR_API_KEY